Taherian et al., 2018 - Google Patents
Optimization of purification procedure for horse F (ab) 2 antivenom against Androctonus crassicauda (Scorpion) venomTaherian et al., 2018
View PDF- Document ID
- 16950741362169133973
- Author
- Taherian A
- Fazilati M
- Moghadam A
- Tebyanian H
- Publication year
- Publication venue
- Tropical journal of pharmaceutical research
External Links
Snippet
Purpose: To immunize antiserum of horse with Androctonus crassicauda scorpion venom in order to achieve an antivenom with higher purity by combined caprylic acid/ammonium sulfate. Methods: The optimum pH to terminate enzymatic digestion was evaluated …
- 230000002303 anti-venom 0 title abstract description 34
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Taherian et al. | Optimization of purification procedure for horse F (ab) 2 antivenom against Androctonus crassicauda (Scorpion) venom | |
| Jones et al. | Enhanced pepsin digestion: a novel process for purifying antibody F (ab′) 2 fragments in high yield from serum | |
| Thalley et al. | Rattlesnake and scorpion antivenoms from the egg yolks of immunized hens | |
| Sjostrom et al. | A comparison of ovine and equine antivenoms | |
| US8512706B2 (en) | Compositions of F(ab′)2 antibody fragments | |
| Liu et al. | Preparation and neutralization efficacy of IgY antibodies raised against Deinagkistrodon acutus venom | |
| de Almeida et al. | Development of process to produce polyvalent IgY antibodies anti-African snake venom | |
| Squaiella-Baptistao et al. | Anticomplementary activity of horse IgG and F (ab') 2 antivenoms | |
| Raweerith et al. | Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography | |
| Eursakun et al. | Studies on the fractionation of equine antivenom IgG by combinations of ammonium sulfate and caprylic acid | |
| Leiva et al. | IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy | |
| Al-Abdulla et al. | Single-reagent one-step procedures for the purification of ovine IgG, F (ab′) 2 and Fab antivenoms by caprylic acid | |
| Nudel et al. | Optimization by factorial analysis of caprylic acid precipitation of non-immunoglobulins from hyperimmune equine plasma for antivenom preparation | |
| Zurbano et al. | Critical aspects on traditional antivenom production processes and their optimization by factorial analysis | |
| Meenatchisundaram et al. | Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies | |
| Guidlolin et al. | Polyvalent horse F (Ab) 2 snake antivenom: Development of process to produce polyvalent horse F (Ab) 2 antibodies anti-african snake venom | |
| Raweerith et al. | Immunochemical and biochemical comparisons of equine monovalent and polyvalent snake antivenoms | |
| Guidolin et al. | Characterization of anti-crotalic antibodies | |
| JP3666872B2 (en) | Anti-toxin antibody composition, preparation method thereof and use thereof | |
| Redwan et al. | Production and purification of ovine anti-tetanus antibody | |
| Kalil et al. | Production and utilization of snake antivenoms in South America | |
| Norouznejad et al. | Purification of Therapeutic Serums of Snake Anti-Venom with Caprylic Acid | |
| Theakston et al. | Therapeutic antibodies to snake venoms | |
| da Costa et al. | Production of hyperimmune sera: a study of digestion and fractionation methodologies for the purification process of heterologous immunoglobulins | |
| KR20080108556A (en) | Chigunya-specific immunoglobulin concentrate acting as a drug |